The Incisionless Operating Platform
Enabling Incisionless Surgery
The Incisionless Operating Platform
Enabling Incisionless Surgery
TransPort
4 Channel Overtube & Access Device
The TransPort provides four working channels for accessing gastric tissue and the ability to utilize a variety of endoscopic tools. Steerable just like an endoscope, with lockable positioning to provide a stable platform for endoscopic procedures.
TransPort
4 Channel Overtube & Access Device
The TransPort provides four working channels for accessing gastric tissue and the ability to utilize a variety of endoscopic tools. Steerable just like an endoscope, with lockable positioning to provide a stable platform for endoscopic procedures.
g-Cath EZ
Snowshoe Suture Delivery Catheter
Includes a single anchor pair, easily delivered to approximate gastric tissue with tactile cinching capability.
g-Cath EZ
Snowshoe Suture Delivery Catheter
Includes a single anchor pair, easily delivered to approximate gastric tissue with tactile cinching capability.
g-Prox EZ
Endoscopic Tissue Grasper
Jaws of the g-Prox are used to grasp gastric tissue and approximate a tissue fold in preparation for delivering the Snowshoe Suture Anchors. Loadable and unloadable with repeated uses of the g-Cath.
g-Prox EZ
Endoscopic Tissue Grasper
Jaws of the g-Prox are used to grasp gastric tissue and approximate a tissue fold in preparation for delivering the Snowshoe Suture Anchors. Loadable and unloadable with repeated uses of the g-Cath.
g-Lix
Endoscopic Tissue Retractor
Employs a helical coil tip for initially grasping the gastric tissue and retracting into the jaws of the g-Prox
g-Lix
Endoscopic Tissue Retractor
Employs a helical coil tip for initially grasping the gastric tissue and retracting into the jaws of the g-Prox
In the United States, USGI Medical’s devices are cleared by the FDA for approximation of soft tissue in minimally invasive gastroenterology procedures. The use of USGI Medical’s devices to treat obesity is currently under FDA Investigation.
USGI Medical has CE Mark Indication for the use of its devices for approximation of soft tissue in minimally invasive gastroenterology procedures, including use in obesity intervention for BMI 30 - 40.
In the United States, USGI Medical’s devices are cleared by the FDA for approximation of soft tissue in minimally invasive gastroenterology procedures. The use of USGI Medical’s devices to treat obesity is currently under FDA Investigation.
USGI Medical has CE Mark Indication for the use of its devices for approximation of soft tissue in minimally invasive gastroenterology procedures, including use in obesity intervention for BMI 30 - 40.